BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15842731)

  • 1. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.
    Khabir A; Karray H; Rodriguez S; Rosé M; Daoud J; Frikha M; Boudawara T; Middeldorp J; Jlidi R; Busson P
    Virol J; 2005 Apr; 2():39. PubMed ID: 15842731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of c-kit in North African nasopharyngeal carcinomas: correlation with age and LMP1].
    Charfi S; Khabir A; Ayadi L; Mseddi M; Makni H; Gorbel A; Daoud J; Frikha M; Jlidi R; Busson P; Boudawara TS
    Cancer Radiother; 2007 Sep; 11(5):247-51. PubMed ID: 17689127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response.
    Gondhowiardjo S
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():323-31. PubMed ID: 10895175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
    Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
    Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.
    Hadhri-Guiga B; Khabir AM; Mokdad-Gargouri R; Ghorbel AM; Drira M; Daoud J; Frikha M; Jlidi R; Gargouri A
    Virus Res; 2006 Jan; 115(1):24-30. PubMed ID: 16154221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
    Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF
    Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma.
    Houali K; Wang X; Shimizu Y; Djennaoui D; Nicholls J; Fiorini S; Bouguermouh A; Ooka T
    Clin Cancer Res; 2007 Sep; 13(17):4993-5000. PubMed ID: 17785549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D; Srivatanakul P; Karalak A; Ishida T
    J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.
    Keryer-Bibens C; Pioche-Durieu C; Villemant C; Souquère S; Nishi N; Hirashima M; Middeldorp J; Busson P
    BMC Cancer; 2006 Dec; 6():283. PubMed ID: 17156439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease.
    Meij P; Vervoort MB; Bloemena E; Schouten TE; Schwartz C; Grufferman S; Ambinder RF; Middeldorp JM
    J Med Virol; 2002 Nov; 68(3):370-7. PubMed ID: 12226824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
    Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
    J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of an XhoI-site within N-terminal region of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma.
    Lin SX; Zong YS; Wu QL; Han AJ; Liang YJ
    Ai Zheng; 2003 Nov; 22(11):1147-51. PubMed ID: 14613641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
    Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
    Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor (EGFR) abundance correlates with p53 and Bcl-2 accumulation and patient age in a small cohort of North African nasopharyngeal carcinoma patients.
    Bourouba M; Benyelles-Boufennara A; Terki N; Baraka-Kerboua E; Bouzid K; Touil-Boukoffa C
    Eur Cytokine Netw; 2011 Mar; 22(1):38-44. PubMed ID: 21388911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of multidrug resistance 1 and glutathione-S-transferase-Pi protein in nasopharyngeal carcinoma.
    Chen CL; Sheen TS; Lou IU; Huang AC
    Hum Pathol; 2001 Nov; 32(11):1240-4. PubMed ID: 11727264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
    Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
    Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.